NovaSource Power Services is World’s Largest Solar O&M Provider with Acquisition of First Solar’s North American O&M Business

PR Newswire

AUSTIN, Texas, March 31, 2021 /PRNewswire/ — NovaSource Power Services (“NovaSource” or the “Company”), a portfolio company of Clairvest Group Inc. (“Clairvest”, TSX: CVG), has closed its previously announced acquisition and corresponding merger with the North American operations and maintenance (“O&M”) business of First Solar, Inc. (“First Solar”, NASDAQ: FSLR). The combined business will operate as NovaSource Power Services.

NovaSource is now the largest global solar operations and maintenance workforce, with over 700 dedicated service technicians serving the utility, industrial, commercial, and residential solar markets, as well as EV charging station infrastructure. The combined resources will provide the solar industry with an independent market leader focused on enabling the growth of the renewable energy infrastructure through safe, professional, and reliable O&M services.

“We’re excited to partner with the First Solar O&M team to make NovaSource the most innovative and best-in-class solar O&M company in the world. The opportunities that lie ahead to maximize value for our customers are significant and joining forces will allow us to build upon each other’s strengths and invest in all areas critical to the business, including digital platforms, field operations, supply chain, customer service and much more,” said Jack Bennett, Chief Executive Officer of NovaSource.

“Establishing the market leading solar O&M company as a truly independent business allows NovaSource to better focus on maximizing the ROI of our customers’ assets,” said Troy Lauterbach, President, Chief Growth Officer of NovaSource. “Clairvest’s support should enable us to maintain our market leadership and deliver the highest levels of customer satisfaction.”

About NovaSource

NovaSource Power Services is a global O&M services provider for renewable energy assets. NovaSource seeks to maintain a world-class culture of safety and integrity, while developing lasting partnerships with our customers and team members. Founded in 2020, the NovaSource team has worked at the forefront of the renewables industry for more than 20 years and manages over 16 GW of residential, commercial, industrial, and utility scale projects. As an independent, O&M-focused company, NovaSource is poised to offer even greater value in the design, maintenance, and management of our customers’ projects.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/novasource-power-services-is-worlds-largest-solar-om-provider-with-acquisition-of-first-solars-north-american-om-business-301260152.html

SOURCE NovaSource Power Services

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against XL Fleet Corp. (XL)

Shareholders with $50,000 losses or more are encouraged to contact the firm

LOS ANGELES, March 31, 2021 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 7, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired XL Fleet Corp. (“XL Fleet” or the “Company”) (NYSE: XL) securities between October 2, 2020 and March 2, 2021, inclusive (the “Class Period”).

If you suffered a loss on your XL Fleet investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/xl-fleet-corp/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

On March 3, 2021, Muddy Waters Research published a report entitled “XL Fleet Corp. (NYSE: XL): More SPAC Trash,” alleging, among other things, that salespeople “were pressured to inflate their sales pipelines materially in order to mislead XL’s board and investors” and that “customer reorder rates are in reality quite low” due to “poor performance and regulatory issues.” Citing interviews with former employees, the report alleged that “at least 18 of 33 customers XL featured were inactive.” Muddy Waters also claimed that XL has “weak technology” and that “XL’s announcement of future class 7-8 upfits seems highly promotional” because the task is “too technologically complex for XL engineers to deliver on the promised timeline.”

On this news, the Company’s stock price fell $2.09, or 13%, to close at $13.86 per share on March 3, 2021, on unusually heavy trading volume. The share price continued to decline by $2.69, or 19.4%, over two consecutive trading sessions to close at $11.17 per share on March 5, 2021, on unusually heavy trading volume.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that XL Fleet’s salespeople were pressured to inflate their sales pipelines to boost the Company’s reported sales and backlog; (2) that at least 18 of the 33 customers that XL featured were inactive and had not placed an order since 2019; (3) that XL’s technology had been materially overstated and offered only 5% to 10% of fleet savings; (4) that XL lacks the supply chain and engineers to roll out new products on the announced timelines; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired XL Fleet securities during the Class Period, you may move the Court no later than May 7, 2021 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
[email protected]
www.glancylaw.com



ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lordstown Motors Corp. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – RIDE

PR Newswire

NEW YORK, March 31, 2021/PRNewswire/ — WHY: New York, N.Y., March 31, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Lordstown Motors Corp. (NASDAQ: RIDE) between August 3, 2020 and March 17, 2021, inclusive (the “Class Period”), of the important May 17, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Lordstown securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Lordstown class action, go to http://www.rosenlegal.com/cases-register-2056.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE:  According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Lordstown’s purported pre-orders were non-binding; (2) many of the would-be customers who made these purported pre-orders lacked the means to make such purchases and/or would not have credible demand for Lordstown’s Endurance; (3) Lordstown is not and has not been “on track” to commence production of the Endurance in September 2021; (4) the first test run of the Endurance led to the vehicle bursting into flames within 10 minutes; and (5) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Lordstown class action, go to http://www.rosenlegal.com/cases-register-2056.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-global-investor-counsel-encourages-lordstown-motors-corp-investors-with-losses-exceeding-100k-to-secure-counsel-before-important-deadline-in-securities-class-action–ride-301260117.html

SOURCE Rosen Law Firm, P.A.

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Repro Med Systems, Inc. Investors with Losses to Secure Counsel Before Important Deadline – KRMD

PR Newswire

NEW YORK, March 31, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Repro Med Systems, Inc. (NASDAQ: KRMD) between August 4, 2020 and January 25, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 25, 2021.

SO WHAT: If you purchased Repro Med securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Repro Med class action, go to http://www.rosenlegal.com/cases-register-2068.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 25, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE:  According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) starting in January 2020, Repro ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, Repro Med’s net sales were reasonably likely to decline; and (3) as a result of the foregoing, Defendants’ positive statements about Repro Med’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To join the Repro Med class action, go to http://www.rosenlegal.com/cases-register-2068.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-a-globally-recognized-firm-encourages-repro-med-systems-inc-investors-with-losses-to-secure-counsel-before-important-deadline–krmd-301260111.html

SOURCE Rosen Law Firm, P.A.

MOUNT SAINT MARY’S UNIVERSITY RELEASES COMPREHENSIVE REPORT ON PANDEMIC’S IMPACT ON WOMEN AND GIRLS

Report highlights gender inequities exacerbated by COVID-19 crisis

Los Angeles, March 31, 2021 (GLOBE NEWSWIRE) — Mount Saint Mary’s University (MSMU), Los Angeles, today released its 10th annual Report on the Status of Women and Girls in California. This year’s report, The Impact of COVID-19: Amplifying Inequities, is the most comprehensive study in California on the impact of the pandemic on women and girls in the state.

 “We knew we had to produce a comprehensive, timely report that examined the pandemic and how it has disproportionately affected women and girls,” said Ann McElaney-Johnson, President of MSMU. “The pandemic has underscored that gender, race, ethnicity and socio-economic status continue to determine women and girls’ health, wellness, safety, access to education, and economic security.”

The report was developed by the Center for the Advancement of Women at MSMU. Its findings were announced today during a virtual event that gathered leaders from various industries to discuss the report, how women are faring in the wake of COVID-19, and how we can our communities can recover without jeopardizing the gains women have towards gender parity in the last decade.

At the event, Los Angeles County Supervisors Kathryn Barger, Sheila Kuehl and Holly J. Mitchell discussed leading Los Angeles out of the pandemic, the historic nature of an all-female LA County Board of Supervisors, and what women’s leadership means for the most powerful local government body in the country.

“I think we have a deep sensibility to the unique needs of our constituents. We, in our ordinary life experience, understand the dynamics that our constituents experience every day and we govern from that space,” said Supervisor Mitchell. “There is too much work to do. There is more work to be done than any of us hope to accomplish individually so we understand collectively we’re stronger. So, we just get it done. And I think that’s what makes an elected body of all women unique, and quite frankly beneficial to our shared constituents.”

To access the 2021 Report on the Status of Women and Girls in California: https://www.msmu.edu/center-for-the-advancement-of-women/events/status-of-women-and-girls/read-the-latest-report/

Watch The Report event: https://www.facebook.com/MountSaintMarysU/videos/2882776225338414

ABOUT MOUNT SAINT MARY’S UNIVERSITY

Mount Saint Mary’s is the only women’s university in Los Angeles and one of the most diverse in the nation. The University is known nationally for its research on gender equality, its innovative health and science programs, and its commitment to community service.

As a leading liberal arts institution, Mount Saint Mary’s provides year-round, flexible, and online programs at the undergraduate and graduate level. Weekend, evening, and graduate programs are offered to both women and men. Mount alums are engaged, active global citizens who use their knowledge and skills to better themselves, their communities and the world.

msmu.edu

ABOUT THE CENTER FOR THE ADVANCEMENT OF WOMEN

The Center for the Advancement of Women at Mount Saint Mary’s University is a hub for gender equity research, advocacy and leadership development. Its vision is to find solutions to persistent gender inequities and work with partners to eradicate those inequities in our lifetime. That goal includes eliminating obstacles that women face in the workplace, in their communities, in the media and beyond to make a positive difference in the lives of women and girls in California and our nation. The Center also creates public programming, research guides and training opportunities to engage more partners in its work.

Center for the Advancement of Women

 



Debbie Ream
Mount Saint Mary's University
[email protected]

Horizonte Minerals Plc: Amended Technical Reports

LONDON, March 31, 2021 (GLOBE NEWSWIRE) — Horizonte Minerals Plc, (AIM: HZM, TSX: HZM) (‘Horizonte’ or ‘the Company’) the nickel company focused on Brazil, reports that it has filed on SEDAR: (i) an amended technical report for its Araguaia project entitled “Amended NI 43-101 Technical Report Feasibility Study for the Araguaia Nickel Project, Federative Republic of Brazil, Project Number AU9867” (the “Araguaia Report”), (ii) an amended technical report for its Vermelho project entitled “Amended NI43-101 Technical Report – Vermelho Project, Pará State, Brazil” (the “Vermelho Report”), and (iii) an amended technical report for its Serra do Tapa project entitled “Amended NI 43-101 Technical Report on the Serra do Tapa Project, Pará State, Brazil” (the “Serra Do Tapa Report” and, collectively with the Araguaia Report and the Vermelho Report, the “Technical Reports”). The purpose of amendments to the Technical Reports is to provide corrective disclosure as a result of a review by staff of the Ontario Securities Commission of the preliminary short form prospectus of the Company dated and filed on March 15, 2021.

The Araguaia Report was amended to remove disclosure relating to the Stage 2 expansion under Section 1.18.2 – “Opportunities – Increased plant capacity” as well as to remove the economic analysis based on the long term forecasted Nickel price of US$26,450/t under Section 22.1 – “Economic Analysis – Project economic headline results”.

The Vermelho Report was amended to remove disclosure about the cash flow estimates combining feed from both the Vermelho project and the Serra do Tapa project under Section 1.18.2 – “Opportunities – Opportunity to develop the Project as a ferronickel project”.

The Serra Do Tapa Report was amended to remove the addition of inferred mineral resources with measured mineral resources and indicated mineral resources in Table 14.6.

The conclusions and recommendations in the Technical Reports remain the same and unchanged from their original publication dates and, in the Company’s view, none of the changes made in the Technical Reports are material to the assets or operations of the Company.

For further information, visit

www.horizonteminerals.com

or contact:

Horizonte Minerals plc
[email protected]
Jeremy Martin (CEO) +44 (0) 203 356 2901
Anna Legge (Corporate Communications)  
 
Peel Hunt (NOMAD & Joint Broker)
+44 (0)20 7418 8900
Ross Allister  
David McKeown  
   
BMO (Joint Broker)
+44 (0) 20 7236 1010
Thomas Rider  
Pascal Lussier Duquette  
Andrew Cameron  

About Horizonte Minerals:

Horizonte Minerals plc is an AIM and TSX-listed nickel development company focused in Brazil. The Company is developing the Araguaia project, as the next major ferronickel mine in Brazil, and the Vermelho nickel-cobalt project, with the aim of being able to supply nickel and cobalt to the EV battery market. Both projects are 100% owned.

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION

Except for statements of historical fact relating to the Company, certain information contained in this press release constitutes “forward-looking information” under Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the potential of the Company’s current or future property mineral projects; the success of exploration and mining activities; cost and timing of future exploration, production and development; the estimation of mineral resources and reserves and the ability of the Company to achieve its goals in respect of growing its mineral resources; and the realization of mineral resource and reserve estimates. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, and are inherently subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to risks related to: exploration and mining risks, competition from competitors with greater capital; the Company’s lack of experience with respect to development-stage mining operations; fluctuations in metal prices; uninsured risks; environmental and other regulatory requirements; exploration, mining and other licences; the Company’s future payment obligations; potential disputes with respect to the Company’s title to, and the area of, its mining concessions; the Company’s dependence on its ability to obtain sufficient financing in the future; the Company’s dependence on its relationships with third parties; the Company’s joint ventures; the potential of currency fluctuations and political or economic instability in countries in which the Company operates; currency exchange fluctuations; the Company’s ability to manage its growth effectively; the trading market for the ordinary shares of the Company; uncertainty with respect to the Company’s plans to continue to develop its operations and new projects; the Company’s dependence on key personnel; possible conflicts of interest of directors and officers of the Company, the inability of the Company to complete the Placing on the terms as described herein, and various risks associated with the legal and regulatory framework within which the Company operates. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise unless required to do so by applicable law or regulation.



Vireo Health and Former Executive Chairman Enter into Mutual Release

PR Newswire

MINNEAPOLIS, March 31, 2021 /PRNewswire/ — Vireo Health International Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced that it has entered into a mutual release (the “Mutual Release“) with Bruce Linton, a globally recognized authority in cannabinoid policy and business and the Company’s former Executive Chairman, relating to all outstanding matters between them.

Mr. Linton joined Vireo in November of 2019. On June 8, 2020, the Company elected to terminate its employment agreement with Mr. Linton as Executive Chairman, on an entirely without-cause basis. In connection with Mr. Linton’s employment agreement, Mr. Linton received warrants (the “Warrants“) to acquire up to 15 million subordinate voting shares (each, a “Share“) in the Company. 10 million of the Warrants (the “First TrancheWarrants“) have an exercise price of US$1.02 per Share.

As part of the Mutual Release, Vireo has issued 8,000,000 Shares to Mr. Linton.  7,110,381 Shares were issued to Mr. Linton pursuant to the exercise of the First Tranche Warrants on a cashless basis.  The remaining 889,519 Shares were issued to Mr. Linton pursuant to a private placement exemption resulting in no cash consideration being paid to Vireo.  The Shares issued pursuant to the First Tranche Warrants are free of trading restrictions and the 889,519 Shares are subject to a hold period expiring on August 1, 2021.  In addition, as part of the Mutual Release, Mr. Linton has surrendered all right, title and interest in all other Warrants for cancellation.

The issuance of Shares pursuant to the Debt Settlement constitutes a “related party transaction” as this term is defined in Multilateral Instrument 61-101 – Protection of Minority Securityholders in Special Transactions (“MI 61-101“). All of the independent directors of the Company, acting in good faith, determined that the fair market value of the Shares being issued pursuant to the Debt Settlement and the consideration being paid is reasonable. The Company intends to rely on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 as neither the fair market value of the Shares nor the debt exceeds 25% of the Company’s market capitalization. The Company did not file a material change report more than 21 days before the expected closing of the Debt Settlement as the details and amounts of debts settled under the transaction were not finalized until closer to the closing and the Company wished to close the Debt Settlement as soon as practicable. All Shares issued to pursuant to the Debt Settlement  will be subject to a four (4) month hold period.

About Vireo Health International, Inc.

Vireo Health International, Inc. is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally friendly facilities, state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods™ and other retail locations and third-party dispensaries. Vireo’s team of more than 400 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in nine markets and operates 16 dispensaries nationwide. Vireo holds additional retail licenses in four markets. For more information about Vireo Health, please visit www.vireohealth.com.  The Canadian Securities Exchange (“CSE”) has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its “regulation services provider” (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Contact Information


Media Inquiries

Albe Zakes
Vice President, Corporate Communications
[email protected]
(267) 221-4800


Investor Inquiries


Sam Gibbons

Vice President, Investor Relations

[email protected] 
(612) 314-8995

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/vireo-health-and-former-executive-chairman-enter-into-mutual-release-301260098.html

SOURCE Vireo Health International, Inc.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Plug Power, XL Fleet Corp., Bellus Health, and Neptune Wellness and Encourages Investors to Contact the Firm

NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Plug Power, Inc. (NASDAQ: PLUG), XL Fleet Corp. (NYSE: XL), Bellus Health, Inc. (NASDAQ: BLU), and Neptune Wellness Solutions, Inc. (NASDAQ: NEPT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Plug Power, Inc. (NASDAQ: PLUG)

Class Period: November 9, 2020 to March 1, 2021

Lead Plaintiff Deadline: May 7, 2021

On March 2, 2021, before the market opened, Plug filed a Notification of Late Filing with the SEC stating that it could not timely file its annual report for the period ended December 31, 2020 because the Company was completing a “review and assessment of the treatment of certain costs with regards to classification between Research and Development versus Costs of Goods Sold, the recoverability of right of use assets associated with certain leases, and certain internal controls over these and other areas.” The Company stated that “[i]t is possible that one or more of these items may result in charges or adjustments to current and/or prior period financial statements.”

On this news, the Company’s stock price fell $3.68, or 7%, to close at $48.78 per share on March 2, 2021. The share price continued to decline by $9.48, or 19.4%, over three consecutive trading sessions to close at $39.30 per share on March 5, 202.

The complaint, filed on March 8, 2021, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that the Company would be unable to timely file its 2020 annual report due to delays related to the review of classification of certain costs and the recoverability of the right to use assets with certain leases; (2) that the Company was reasonably likely to report material weaknesses in its internal control over financial reporting; and (3) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

For more information on the Plug Power class action go to: https://bespc.com/cases/PLUG

XL Fleet Corp. (NYSE: XL)

Class Period: September 2, 2020 to March 2, 2021

Lead Plaintiff Deadline: May 7, 2021

On March 3, 2021, Muddy Waters Research published a report entitled “XL Fleet Corp. (NYSE: XL): More SPAC Trash,” alleging, among other things, that salespeople “were pressured to inflate their sales pipelines materially in order to mislead XL’s board and investors” and that “customer reorder rates are in reality quite low” due to “poor performance and regulatory issues.” Citing interviews with former employees, the report alleged that “at least 18 of 33 customers XL featured were inactive.” Muddy Waters also claimed that XL has “weak technology” and that “XL’s announcement of future class 7-8 upfits seems highly promotional” because the task is “too technologically complex for XL engineers to deliver on the promised timeline.”

On this news, the Company’s stock price fell $2.09, or 13%, to close at $13.86 per share on March 3, 2021. The share price continued to decline by $2.69, or 19.4%, over two consecutive trading sessions to close at $11.17 per share on March 5, 2021.

The complaint, filed on March 8, 2021, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that XL Fleet’s salespeople were pressured to inflate their sales pipelines to boost the Company’s reported sales and backlog; (2) that at least 18 of the 33 customers that XL featured were inactive and had not placed an order since 2019; (3) that XL’s technology had been materially overstated and offered only 5% to 10% of fleet savings; (4) that XL lacks the supply chain and engineers to roll out new products on the announced timelines; and (5) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

For more information on the XL Fleet class action go to: https://bespc.com/cases/XL

Bellus Health, Inc. (NASDAQ: BLU)

Class Period: September 5, 2019 to July 5, 2020

Lead Plaintiff Deadline: May 17, 2021

Bellus is a clinical-stage biopharmaceutical company whose lead product is BLU-5937, which is being developed for the treatment of chronic cough (one that lasts over eight weeks) and other afferent hypersensitization-related disorders.

Before markets opened on July 6, 2020, defendants revealed the truth about BLU5937’s efficacy. They announced that the drug had failed a Phase 2 study of chronic cough patients for whom other treatments had not worked. Specifically, BLU-5937 was not significantly better than a placebo at reducing the frequency at which patients coughed. The Phase 2 trial showed a “clinically meaningful and highly statistically significant” effect only on a subset of patients who had high cough counts (around 32 per day), so the Company was planning a Phase 2b trial focused on those patients.

On this news, indicating that Bellus had fallen even further behind Merck in developing an FDA-approved treatment for refractory chronic cough, the Company’s stock price plummeted over 75% to close at $2.97 on July 8, 2020.

The complaint, filed on March 16, 2021, alleges that defendants’ scheme: (i) deceived the investing public regarding Bellus’s business, operations, drug products, drug product development, competition, and present and future business prospects; (ii) facilitated the Company’s September 2019 public offering (“Offering”); (iii) created artificial demand for the Bellus common shares sold in the Offering; (iv) enabled the Company to receive approximately $70 million in net proceeds from the sale of Bellus common stock in the Offering; and (v) caused Plaintiff and the Class to purchase Bellus publicly traded common stock at artificially inflated prices.

For more information on the Bellus Health class action go to: https://bespc.com/cases/BLU

Neptune Wellness Solutions, Inc. (NASDAQ: NEPT)

Class Period: July 24, 2019 to February 16, 2021

Lead Plaintiff Deadline: May 17, 2021

On May 9, 2019, Neptune announced that it had signed a definitive agreement to acquire the assets of SugarLeaf Labs, LLC and Forest Remedies LLC (collectively, “SugarLeaf”), a registered North Carolina-based commercial hemp company providing extraction services and formulated products (the “SugarLeaf Acquisition”). On July 24, 2019, Neptune announced the closing of the SugarLeaf Acquisition.

On February 15, 2021, Neptune announced disappointing financial results for the third quarter of the Company’s fiscal year 2021, missing analyst expectations. Among other results, Neptune reported third quarter revenues of CA$3.32 million and a net loss of CA$73.8 million, down 63.81% and over 1,000% year-over-year, respectively. Neptune attributed the net loss, in part, to a CA$35.6 million impairment of goodwill and a CA$2.1 million impairment of “property, plant and equipment and right-of-use assets related to the acquisition of SugarLeaf in July 2019,” as well as accelerated amortization of CA$13.95 million “also related to the SugarLeaf acquisition.” Additionally, the Company disclosed that its “[g]ross margin declined to a loss of 268.3%,” which included a non-cash CA$7.39 million “write-down of inventory and deposits to reflect their net realizable value.”

On this news, Neptune’s stock price fell $0.86 per share, or 30.71%, to close at $1.94 per share on February 16, 2021.

Then, on February 17, 2021, prior to the start of the day’s trading session, Neptune issued a press release announcing the termination of an at-the-market offering conducted by the Company, selling 9,570,735 of its common shares and raising approximately $18.6 million in gross proceeds. Just minutes later, Neptune issued a second press release announcing that the Company was conducting a $55 million registered direct offering.

On this news, Neptune’s stock price fell another $0.21 per share, or 10.82%, to close at $1.73 per share on February 17, 2021.

The complaint, filed on March 16, 2021, alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune’s integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company’s capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

For more information on the Neptune Wellness class action case go to: https://bespc.com/cases/NEPT

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com



Mitsubishi Chemical Optimizes Global MMA Product Supply Network, Unifies Regional MMA Operations Under New Name—Mitsubishi Chemical Methacrylates

Mitsubishi Chemical Optimizes Global MMA Product Supply Network, Unifies Regional MMA Operations Under New Name—Mitsubishi Chemical Methacrylates

Major regional subsidiaries such as Lucite International change their name

TOKYO–(BUSINESS WIRE)–
Companies under the Mitsubishi Chemical Corporation global Methyl-methacrylate (MMA) Domain unify today under a new name, Mitsubishi Chemical Methacrylates. Major regional subsidiaries in the Americas, Asia and Europe, including former Lucite International, have changed their name as part of this unification.

Mitsubishi Chemical also consolidates its MMA headquarters in Singapore, which provides business oversight for 11 monomer plants and 6 polymer (acrylic resin) plants in growth markets around the globe.

The new name is part of a long-term plan to integrate regional companies within the company’s MMA Domain to further optimize its global product supply network. Mitsubishi Chemical leverages digital technologies to connect regional production, costs and supply to meet the global demand for MMA. On average, the global demand for MMA increases 3% annually.

“The formation of Mitsubishi Chemical Methacrylates demonstrates our commitment to providing reliable MMA supply to our customers in every corner of the world,” said Hitoshi Sasaki, chief executive officer, Mitsubishi Chemical Methacrylates. “This ties into our focus on expanding businesses in our portfolio that are poised for growth while simultaneously contributing to solving environmental and social issues.”

About Mitsubishi Chemical Corporation

Mitsubishi Chemical Corporation creates innovative solutions globally based on our core values of sustainability, health and comfort, striving for the well-being of people, society and our planet Earth. Learn more at www.m-chemical.co.jp/en.

About Mitsubishi Chemical Methacrylates

Mitsubishi Chemical Methacrylates (MCM) is the global Methacrylates Division of Mitsubishi Chemical. With manufacturing sites, sales offices and distribution networks stretching across Asia, the Americas and Europe, MCM creates products that improve quality of life around the world, every single day. Learn more at www.mcc-methacrylates.com.

For additional information, contact:

Media

Americas

Robin Goodman

Tel: +1 (901) 381-2241

[email protected]

EMEA

Scott Neal

Tel: +44 (0)1642 735066

[email protected]

Asia Pacific

Quee May Tan

Tel: +65 6303 4830

[email protected]

Japan

Kozo Hisamoto

Tel: +81 (0) 80 9434 5061

[email protected]

KEYWORDS: Asia Pacific Europe China Japan Singapore

INDUSTRY KEYWORDS: Chemicals/Plastics Environment Manufacturing

MEDIA:

Logo
Logo

Intermap Announces Filing of 2020 Annual Results

PR Newswire

COVID-19 delayed but did not cancel aviation projects

Government pipeline is robust and will support future revenue

Software subscriptions renewed at higher prices for additional services

DENVER, March 31, 2021 /PRNewswire/ – Intermap Technologies (TSX: IMP) (OTCQX: ITMSF) (“Intermap” or the “Company”), a global leader in geospatial intelligence solutions, today filed its audited annual financial statements for the year ended December 31, 2020, the annual management discussion and analysis for the corresponding period, related management certifications of annual filings and its annual information form. The documents are available on SEDAR at www.sedar.com.

Consolidated revenue for the year ended December 31, 2020 totaled $4.7 million, compared to $10.1 million for 2019, reflecting the disruption from the COVID-19 pandemic. The decline was expected and due entirely to delayed government contracts given the economic environment resulting from the pandemic. Approximately 71% of consolidated revenue was generated outside the United States, compared to 41% for 2019.

Net income improved from a loss of $4.8 million to income of $26.6 million for the years ended December 31, 2020 and 2019, respectively, due to the gain on the modification of debt of $32.1 million, offset by the reduction in revenue discussed above.

In a year that was filled with global business disruption, Intermap achieved significant milestones necessary to grow the business. With the elimination of $33.9 million notes payable and the rebuilding of the government pipeline, the Company is well-positioned for growth. Intermap also welcomed sophisticated investors through fully subscribed issuer private placements while maintaining the value of its tax assets.

Software-based subscription revenue grew 4% during 2020, a year in which the insurance industry was especially challenged by COVID-19. At the same time, Intermap was successful in extending all customer contracts that were up for renewal during the year. The Company’s software customers are renewing their subscriptions at higher rates, adding new services to their accounts and expanding the geographies and business lines where they’re doing business with Intermap.

Intermap’s acquisition services revenue was significantly affected by the onset of COVID-19. As various U.S. government agencies and contracting vehicles are primary users of Intermap’s data and services, COVID-19 created new gaps in the previous three-year sales cycle.

In fiscal 2021, business is recovering and the pipeline of high-probability opportunities has grown 429%, compared with December 31, 2019. 44% of these opportunities represent repeat customers. Despite the ongoing impact of COVID-19, the pipeline is expected to support revenue and adjusted EBITDA growth in 2021 compared with the amounts achieved in 2020.

Intermap Reader Advisory

Certain information provided in this news release, including
projected financial information and
statements in relation to the Company’s opportunities for growth and pipeline constitutes forward-looking statements. The words “anticipate”, “expect”, “project”, “estimate”, “forecast”, “will be”, “will consider”, “intends” and similar expressions are intended to identify such forward-looking statements. Although Intermap believes that these statements are based on information and assumptions which are current, reasonable and complete, these statements are necessarily subject to a variety of known and unknown risks and uncertainties. Intermap’s forward-looking statements are subject to risks and uncertainties pertaining to, among other things, cash available to fund operations, availability of capital, revenue fluctuations, nature of government contracts, economic conditions, loss of key customers, retention and availability of executive talent, competing technologies, common share price volatility, loss of proprietary information, software functionality, internet and system infrastructure functionality, information technology security, breakdown of strategic alliances, and international and political considerations, as well as those risks and uncertainties discussed Intermap’s Annual Information Form and other securities filings. While the Company makes these forward-looking statements in good faith, should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary significantly from those expected. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what benefits that the Company will derive therefrom. All subsequent forward-looking statements, whether written or oral, attributable to Intermap or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements contained in this news release are made as at the date of this news release and the Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements made herein, whether as a result of new information, future events or otherwise, except as may be required by applicable securities law.

About Intermap Technologies
Founded in 1997 and headquartered in Denver, Colorado, Intermap (TSX: IMP; OTCQX: ITMSF) is a global leader in geospatial intelligence solutions. The Company’s proprietary NEXTMap® database and value-added geospatial data management, processing, analytics, fusion and orthorectification software and solutions are utilized across a range of industries that rely on accurate, high-resolution elevation data, including aviation, engineering, environmental planning, government markets, hydrology, insurance, land management, law enforcement and patrol, oil and gas, renewable energy, telecommunications, transportation and utilities. Intermap’s commercial applications include location-based intelligence, risk assessment, geographic information systems, global positioning systems and 3D visualization. For more information, please visit www.intermap.com.

Cision View original content:http://www.prnewswire.com/news-releases/intermap-announces-filing-of-2020-annual-results-301260136.html

SOURCE Intermap Technologies Corporation